In addition to the optimised intake of dietary fibre, sustained weight loss represents an extremely effective therapy for MAFLD, with the demonstration of reversal of hepatic steatosis and improved hepatic insulin sensitivity and glycaemic control following moderate weight reduction of T2D [114,115]. The gene discussed is INS; the disease is Hepatic steatosis.